FDA advisers vote to include an Omicron-specific component for a coronavirus booster in the US
By Camssvil in News
Updated 2 years ago
The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.